Corona Remedies IPO: Stock Lists at 38% Premium, Makes Strong Dalal Street Debut
1 Comment on Corona Remedies IPO: Stock Lists at 38% Premium, Makes Strong Dalal Street Debut
15/12/2025
Corona Remedies IPO news: Pharma company Corona Remedies made a strong start in the stock market on Monday. The shares were listed at a 38.42% premium over the IPO price of ₹1,062, showing high investor interest. The stock is now trading on both the NSE…